Crossroads: The role of biomarkers in the management of lumps in the breast
A new research perspective was published in Oncotarget's, titled "Crossroads: the role of biomarkers in the management of lumps in the breast."
May 2, 2023
0
12
A new research perspective was published in Oncotarget's, titled "Crossroads: the role of biomarkers in the management of lumps in the breast."
May 2, 2023
0
12
Breast cancer undisputedly has the highest incidence rate in female patients. Moreover, out of the six major cancers, it is the only one that has shown an increasing trend over the past 20 years.
Mar 8, 2023
0
5
According to the ARRS American Journal of Roentgenology (AJR), contrast-enhanced mammography (CEM) may be a useful alternative test for neoadjuvant therapy (NAT) response assessment in patients with breast cancer who are ...
Jun 22, 2022
0
2
According to ARRS' American Journal of Roentgenology (AJR), returning to routine screening for BI-RADS 3 lesions on supplemental automated whole-breast US (ABUS) substantially reduces the recall rate, while being unlikely ...
Jul 15, 2021
0
1
According to ARRS' American Journal of Roentgenology (AJR), new suspicious findings occurred in 5.5% of breast MRI examinations performed to monitor response to neoadjuvant therapy; none of these new lesions were malignant.
Jan 14, 2021
0
5
Women with mammographically detected breast lesions that are probably benign should have follow-up surveillance imaging at six months due to the small but not insignificant risk that the lesions are malignant, according to ...
May 19, 2020
0
2
Breast cancer is the most common form of cancer in women and accounts for 28 % of the total in the World Health Organization European region. Among women, breast cancer represented 3.7 % of all deaths in the EU in 2016, according ...
Apr 13, 2020
0
1
Patients with advanced breast cancer that has spread to the skin are likely to cause more harm than good if they use complementary therapies to treat their skin lesions.
Nov 14, 2019
0
5
During neoadjuvant chemotherapy, new suspicious findings detected on breast magnetic resonance imaging (MRI) during neoadjuvant therapy are most likely benign, according to a study to be presented at the ARRS 2019 Annual ...
May 7, 2019
0
0
Atypical ductal hyperplasia (ADH) is a breast lesion associated with a four- to five-fold increase in the risk of breast cancer. ADH is primarily found using mammography and identified on core needle biopsy. Despite multiple ...
Feb 12, 2019
0
0